Exchange Transfusion in Neonatal Jaundice: Medications, Blood Products & Step-by-Step Protocol

Exchange Transfusion: The Definitive Treatment for Severe Neonatal Jaundice

Exchange transfusion (ET) remains the most effective emergency intervention for severe neonatal hyperbilirubinemia when phototherapy and pharmacological measures fail to prevent dangerous bilirubin levels. This procedure involves the systematic removal and replacement of the neonate's blood in small aliquots, effectively removing bilirubin-laden plasma, antibody-coated red blood cells, and circulating maternal antibodies while providing fresh, compatible red blood cells and plasma proteins.

In India, where delayed presentation of severe jaundice remains common—particularly from rural areas and home deliveries—exchange transfusion is performed more frequently than in many Western countries. The NNF India guidelines provide specific thresholds adapted to the Indian context, and every Level II and Level III NICU should be prepared to perform this procedure. Effective pre-exchange phototherapy using high-irradiance LED units, available through services like HEAMAC phototherapy rental, can reduce the number of neonates requiring this invasive procedure.

Indications for Exchange Transfusion

NNF India Thresholds

Gestational Age	TSB Threshold (Healthy)	TSB Threshold (Risk Factors)
≥38 weeks	25 mg/dL	20-22 mg/dL
35-37 weeks	20-22 mg/dL	18-20 mg/dL
32-34 weeks	18 mg/dL	15-16 mg/dL
<32 weeks	15 mg/dL	12-13 mg/dL

Risk factors that lower the threshold include: isoimmune hemolytic disease, G6PD deficiency, asphyxia, sepsis, acidosis (pH less than 7.15), hypothermia, and hypoalbuminemia (albumin less than 3 g/dL).

Immediate Exchange Transfusion Indications

• Any neonate with signs of acute bilirubin encephalopathy (ABE) regardless of TSB level—hypertonia, retrocollis, opisthotonos, high-pitched cry, fever
• TSB above exchange transfusion threshold on age-specific nomogram
• TSB rising more than 0.5 mg/dL/hour despite intensive phototherapy and IVIG in isoimmune hemolysis
• Cord bilirubin greater than 5 mg/dL with hemoglobin less than 10 g/dL in hydrops fetalis

Blood Products: Selection and Preparation

Blood Selection Guidelines

Condition	Packed RBC Type	Plasma Type	Final Product
Rh HDN	O Rh-negative (or baby's ABO, Rh-negative)	AB or compatible with mother	Reconstituted whole blood, Hct 45-55%
ABO HDN	O Rh-compatible	AB plasma	Reconstituted whole blood, Hct 45-55%
Non-immune jaundice	Baby's ABO and Rh type	Baby's ABO compatible	Reconstituted whole blood, Hct 45-55%
Unknown cause	O Rh-negative	AB plasma	Reconstituted whole blood, Hct 45-55%

Blood Product Requirements

• Freshness: Less than 5 days old (preferably less than 3 days) to minimize hyperkalemia risk
• Irradiation: Gamma-irradiated (25 Gy) to prevent transfusion-associated graft-versus-host disease, recommended by NNF if facility available
• CMV status: CMV-negative or leukoreduced preferred, especially for preterm infants
• Cross-matching: Blood must be cross-matched against maternal serum (not infant serum) in isoimmune cases
• Temperature: Warm to 37 degrees Celsius using approved blood warmer—never use microwave or hot water immersion

Medications Used During Exchange Transfusion

Routine Medications

Medication	Dose	Timing	Purpose
Calcium gluconate 10%	1-2 mL IV slow push	After every 100 mL exchanged	Prevents citrate-induced hypocalcemia
Normal saline 0.9%	2-5 mL flush	Between aliquots as needed	Catheter patency, prevents clotting
Albumin 20% (optional)	1 g/kg IV over 1-2 hours	1-2 hours before exchange	Increases bilirubin-binding, enhances removal

Emergency Medications (Bedside Ready)

• Adrenaline (Epinephrine): 0.01-0.03 mg/kg IV for cardiac arrest or severe bradycardia
• Atropine: 0.02 mg/kg IV for significant bradycardia during procedure
• Sodium bicarbonate 4.2%: 1-2 mEq/kg for documented metabolic acidosis
• Dextrose 10%: 2 mL/kg for hypoglycemia
• Phenobarbital: For seizure management if acute bilirubin encephalopathy develops

Step-by-Step Exchange Transfusion Protocol

Pre-Procedure Preparation

1. Obtain informed consent from parents—explain risks, benefits, and alternatives
2. Confirm blood product availability, cross-match result, and blood warming
3. Place the infant on a radiant warmer with continuous cardiorespiratory monitoring (ECG, SpO2, temperature)
4. Ensure IV access for medications; consider a second peripheral IV line
5. Insert umbilical venous catheter (UVC) under sterile technique—tip in IVC-RA junction (confirm with X-ray if time permits)
6. For push-pull technique: single UVC is sufficient. For isovolumetric technique: UVC for infusion + umbilical arterial catheter (UAC) for withdrawal
7. Keep the infant NPO; insert nasogastric tube for gastric decompression
8. Pre-procedure labs: TSB, CBC, electrolytes (Ca, K, Na, glucose), blood gas, coagulation profile
9. Ensure intensive phototherapy is in progress before, during (if feasible), and after the exchange. HEAMAC LED phototherapy units with overhead configuration can be positioned to provide continuous therapy

During the Procedure

1. Aliquot volume: 5-10 mL/kg per cycle (typically 15-20 mL for a term baby). Use smaller aliquots (5 mL/kg) for preterm and hemodynamically unstable infants
2. Withdraw-infuse cycle: Withdraw blood over 2-3 minutes, discard into waste bag, then infuse fresh blood over 2-3 minutes. Each complete cycle takes 5-7 minutes
3. Total volume: Double volume exchange = 160-180 mL/kg (removes approximately 87% of bilirubin and antibodies)
4. Calcium gluconate: Give 1-2 mL of 10% calcium gluconate slowly after every 100 mL exchanged while monitoring heart rate on ECG
5. Monitor: Heart rate, blood pressure, oxygen saturation, and temperature every 15 minutes. Check blood glucose every 30 minutes
6. Duration: Typically 60-90 minutes for a term infant; do not rush the procedure
7. Record keeping: Maintain a detailed chart of volumes in, volumes out, running balance, medications given, and vital signs

Post-Procedure Care

1. Send immediate post-exchange labs: TSB, CBC, electrolytes, blood glucose, ionized calcium, coagulation profile
2. Resume intensive phototherapy immediately—this is critical to prevent bilirubin rebound
3. Monitor TSB at 1, 2, 4, 6, and 12 hours post-exchange for rebound hyperbilirubinemia
4. Keep UVC in place for 12-24 hours in case repeat exchange is needed
5. Resume feeds cautiously after 4-6 hours if infant is hemodynamically stable
6. Monitor for complications: bleeding, infection, electrolyte disturbances, thrombocytopenia
7. Check platelet count at 24 hours (dilutional thrombocytopenia is common)

Complications and Management

Complication	Incidence	Prevention/Management
Hypocalcemia	30-40%	Routine calcium gluconate after every 100 mL exchanged
Hyperkalemia	10-15%	Use fresh blood (<5 days); monitor ECG for peaked T waves
Thrombocytopenia	50-80%	Dilutional; usually self-resolving; platelet transfusion if <50,000 with bleeding
Catheter-related infection	5-10%	Strict asepsis; prophylactic antibiotics controversial
NEC	1-5%	Keep NPO during and 4-6 hours after; advance feeds slowly
Air embolism	<1%	Ensure all connections are tight; use Luer-lock syringes
Cardiac arrhythmia	2-5%	Slow aliquot exchange; calcium supplementation; ECG monitoring
Mortality	0.3-0.5%	Experienced team; proper monitoring; emergency drugs at bedside

Indian Context: Practical Challenges

Government Hospital Settings

Exchange transfusion in government hospitals faces challenges including limited blood bank hours, difficulty obtaining fresh cross-matched blood quickly, inadequate monitoring equipment, and insufficient trained nursing staff for continuous vital sign monitoring. Many district hospital NICUs may need to transfer neonates to tertiary centers for exchange transfusion, causing critical delays.

Reducing the Need for Exchange Transfusion

The most effective strategy to reduce exchange transfusion rates is early, intensive phototherapy combined with IVIG when indicated. Key measures include:

• Universal bilirubin screening before discharge (TSB or TcB) as recommended by AAP and NNF
• Early intensive phototherapy using high-irradiance LED units—HEAMAC phototherapy rental makes this accessible even in smaller facilities and at home
• Timely IVIG in isoimmune hemolytic disease before TSB reaches exchange threshold
• Parental education on jaundice danger signs and importance of timely follow-up
• Adequate lactation support to prevent dehydration-related jaundice worsening

NNF Key Message: Exchange transfusion is a life-saving procedure but carries significant risks. Every effort should be made to prevent the need through early detection, effective phototherapy, and appropriate pharmacological interventions. HEAMAC phototherapy rental services support this approach by ensuring timely phototherapy access across India.

Post-Exchange Monitoring and Follow-up

Immediate (0-48 hours)

• Serial TSB monitoring (rebound expected in 30-50% of cases within 4-6 hours)
• Continuous intensive phototherapy until TSB is safely below exchange threshold
• CBC with peripheral smear for ongoing hemolysis assessment
• Electrolyte panel, blood glucose, ionized calcium monitoring

Before Discharge

• Stable TSB below phototherapy threshold for 12-24 hours after stopping phototherapy
• Adequate oral feeding established
• Hemoglobin greater than 10 g/dL (or stable with no rapid decline)
• Follow-up appointment within 24-48 hours for TSB recheck and hemoglobin monitoring

Long-term Follow-up

Neonates who required exchange transfusion should undergo developmental screening and auditory brainstem response (ABR) testing to assess for bilirubin-induced neurological dysfunction (BIND). Follow-up hemoglobin monitoring at 2, 4, and 8 weeks is essential, particularly in hemolytic disease cases where late anemia is common and may require iron supplementation or erythropoietin.